Growth Metrics

Intelligent Bio Solutions (INBS) EBIAT (2019 - 2025)

Intelligent Bio Solutions has reported EBIAT over the past 6 years, most recently at -$2.8 million for Q2 2024.

  • For Q2 2024, EBIAT fell 5.13% year-over-year to -$2.8 million; the TTM value through Jun 2024 reached -$10.2 million, up 4.34%, while the annual FY2024 figure was -$10.2 million, 4.15% up from the prior year.
  • EBIAT for Q2 2024 was -$2.8 million at Intelligent Bio Solutions, up from -$3.0 million in the prior quarter.
  • Over five years, EBIAT peaked at -$111107.0 in Q1 2020 and troughed at -$6.3 million in Q1 2023.
  • A 5-year average of -$2.1 million and a median of -$2.0 million in 2020 define the central range for EBIAT.
  • Biggest five-year swings in EBIAT: plummeted 2715.14% in 2021 and later skyrocketed 87.67% in 2022.
  • Year by year, EBIAT stood at -$2.0 million in 2020, then crashed by 74.03% to -$3.5 million in 2021, then skyrocketed by 87.67% to -$427071.0 in 2022, then plummeted by 362.78% to -$2.0 million in 2023, then crashed by 41.44% to -$2.8 million in 2024.
  • Business Quant data shows EBIAT for INBS at -$2.8 million in Q2 2024, -$3.0 million in Q1 2024, and -$2.0 million in Q4 2023.